228850 — Rayence Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeMicro CapContrarian

Market Cap
KR₩88bn
Enterprise Value
-KR₩57bn
Revenue
KR₩126bn

Annual balance sheet for Rayence Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	101,455	118,325	130,731	148,654	150,207
Net Total Accounts Receivable
Net Total Receivables	36,532	39,493	41,619	41,253	34,049
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	167,867	193,871	218,954	236,797	228,632
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	34,589	32,979	23,745	23,882	27,642
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	224,720	241,798	261,999	277,488	269,216
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	19,379	36,862	31,335	30,048	15,881
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	36,552	41,222	37,251	37,266	24,819
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	188,167	200,576	224,748	240,221	244,397
Total Liabilities & Shareholders' Equity	224,720	241,798	261,999	277,488	269,216
Total Common Shares Outstanding